dr. andreadis discusses toxicities with car t-cell therapy
Published 6 years ago • 113 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:42
dr. andreadis discusses fda-approved car t-cell therapies in dlbcl
-
0:55
dr. andreadis on response to car t-cell therapy
-
1:19
dr. andreadis on developments to car t-cell therapy
-
0:43
dr. andreadis on car t-cell therapy for pediatric all
-
0:18
copy of dr. andreadis on response to car t-cell therapy
-
1:41
dr. andreadis on the current state of car t-cell therapy in lymphoma
-
1:11
dr. andreadis on car t-cell therapy in relapsed/refractory mcl
-
1:39
dr. lekakis on managing the toxicity of car t-cell therapy
-
0:53
dr. andreadis on treatment approaches in relapsed mcl
-
0:57
dr. andreadis on the treatment of relapsed dlbcl
-
1:31
dr. andreadis on antibody-drug conjugates in dlbcl
-
12:51
chimeric antigen receptor t-cell therapy in all
-
6:05
r/r dlbcl: car t therapy and immune checkpoint inhibition
-
6:13
lymphoma: overview of chimeric antigen receptor (car) t cells
-
4:16
car t-cell therapy
-
1:53
dr. locke discusses unanswered questions with car t-cell therapy
-
0:56
dr. smith discusses cd19 car t-cell therapy in b-all
-
1:53
alix beaupierre on patient education for car t-cell therapy clinical trials
-
2:46
dr. gordon on the concerns of car t-cell therapy